MARKET

RVMD

RVMD

Revolution Medicines, Inc.
NASDAQ
41.47
+2.70
+6.96%
Pre Market: 40.61 -0.86 -2.07% 08:00 04/29 EDT
OPEN
38.96
PREV CLOSE
38.77
HIGH
41.96
LOW
38.92
VOLUME
12
TURNOVER
0
52 WEEK HIGH
62.40
52 WEEK LOW
29.17
MARKET CAP
7.71B
P/E (TTM)
-11.5916
1D
5D
1M
3M
1Y
5Y
1D
Positive Clinical Data and Competitive Efficacy Drive Buy Rating for Revolution Medicines’ Zoldonrasib
TipRanks · 6h ago
Revolution Medicines shares up 6% after presenting initial RMC-9805 study data
TipRanks · 18h ago
Why Is Cancer Drug Developer Revolution Medicines Stock Trading Higher On Monday?
Benzinga · 21h ago
Revolution Medicines Price Target Maintained With a $67.00/Share by Wedbush
Dow Jones · 22h ago
Wedbush Reiterates Outperform on Revolution Medicines, Maintains $67 Price Target
Benzinga · 23h ago
Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals Ltd. (OtherTLPPF), Encompass Health (EHC) and Revolution Medicines (RVMD)
TipRanks · 1d ago
S&P 500 Futures Drop In Premarket Trading; McCormick Vtg, TPG Lag
Dow Jones · 1d ago
Market-Moving News for April 28th
Benzinga · 1d ago
More
About RVMD
More
Revolution Medicines, Inc. is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. The company’s RAS(ON) inhibitors are daraxonrasib (RMC-6236), an RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), an RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are in clinical development. The Company’s pipeline also focuses on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C).
Recently
Symbol
Price
%Change

Webull offers Revolution Medicines Inc stock information, including NASDAQ: RVMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVMD stock methods without spending real money on the virtual paper trading platform.